Weik Capital Management Pfizer Inc Transaction History

Weik Capital Management

$246 Million
Q3 2024

A detailed history of Weik Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Weik Capital Management holds 35,630 shares of PFE stock, worth $946,332. This represents 0.42% of its overall portfolio holdings.

Number of Shares

35,630

Previous 35,630 -0.0%

Holding current value

$946,332

Previous $996,000 3.51%

% of portfolio

0.42%

Previous 0.43%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $19,323 - $22,644	765 Added 2.19%	35,630 $996,000
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $117,799 - $135,271	4,550 Added 15.01%	34,865 $967,000
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $283,223 - $367,875	-10,839 Reduced 26.34%	30,315 $872,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $12,836 - $15,004	400 Added 0.98%	41,154 $1.37 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $52,373 - $60,595	1,450 Added 3.69%	40,754 $1.49 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $476,815 - $620,744	12,105 Added 44.51%	39,304 $1.6 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $64,712 - $84,475	1,550 Added 6.04%	27,199 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $165,194 - $201,660	3,775 Added 17.26%	25,649 $1.12 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $116,325 - $137,925	2,500 Added 12.9%	21,874 $1.15 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $65,605 - $81,293	1,434 Added 7.99%	19,374 $1 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $64,637 - $73,224	1,800 Added 11.15%	17,940 $703,000
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $53,249 - $60,054	1,590 Added 10.93%	16,140 $585,000
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $15,061 - $19,152	450 Added 3.19%	14,550 $536,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $2,063 - $2,421	65 Added 0.46%	14,100 $517,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $45,180 - $54,810	1,500 Added 11.97%	14,035 $459,000
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $55,006 - $78,591	2,035 Added 19.38%	12,535 $409,000
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $234,050 - $257,832	-7,550 Reduced 41.83%	10,500 $375,000
Q2 2017 Aug 14, 2017	BUY	N/A	18,050	18,050 $606,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weik Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Weik Capital Management with notifications on news.

Account

Weik Capital Management Pfizer Inc Transaction History